BioKangtai's products are constantly moving out of the country and heading for the world. In order to enhance international vaccine cooperation, BioKangtai is actively developing and promoting two leprosy, Haemophilus influenza type B conjugates Vaccine, acellular DPT, Haemophilus influenzae type B, 23-Valent Pneumococcal Polysaccharide Vaccine, hepatitis B vaccine. Registration of 13 valent pneumococcal conjugate vaccine, SARS-CoV-2 inactivated vaccine (vero cell)  and other products in Pakistan, Egypt, Cote d'Ivoire, Uzbekistan, Mongolia, eight African countries, Indonesia, the Philippines, Malaysia, Colombia, Bolivia, Mexico, Brazil, Chile, Bangladesh and other countries.